Gut Instincts: Exploring Microbial and Nutritional Strategies in IBD Care

Dates and Times

Start: 10/15/2025 8:00 AM
End: 10/15/2025 9:00 AM

Objectives

1. Provide an overview of the current therapeutic landscape for inflammatory bowel disease (IBD), including the rationale and limitations of existing medical therapies.
2. Describe the role of diet and the gut microbiota in intestinal homeostasis and disease pathogenesis.
3. Review the evidence supporting microbiota-based interventions, including probiotics and fecal microbiota transplantation (FMT), in ulcerative colitis.
4. Discuss findings from the MINDFUL clinical trial exploring how dietary fiber influences microbial engraftment and treatment outcomes after FMT.
5. Highlight the emerging concept of precision microbiome therapy and its potential to complement current IBD treatments.

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.